Alphatec Holdings logo

Alphatec HoldingsNASDAQ: ATEC

Profile

Sector:

Healthcare

Country:

United States

IPO:

12 June 2006

Next earnings report:

27 February 2025

Last dividends:

N/A

Next dividends:

N/A
$1.44 B
-41%vs. 3y high
78%vs. sector
-vs. 3y high
-vs. sector
-1.06 K
-1166%vs. 3y high
0%vs. sector
-56%vs. 3y high
44%vs. sector

Price

after hours | 24 min ago
$10.14+$0.54(+5.62%)

Dividend

No data over the past 3 years
$150.72 M$170.36 M
$150.72 M-$39.62 M

Analysts recommendations

Institutional Ownership

ATEC Latest News

Alphatec (ATEC) Reports Q3 Loss, Tops Revenue Estimates
zacks.com30 October 2024 Sentiment: POSITIVE

Alphatec (ATEC) came out with a quarterly loss of $0.28 per share versus the Zacks Consensus Estimate of a loss of $0.27. This compares to loss of $0.35 per share a year ago.

Prediction: This Health Care Stock Will Be the Best Performer the Rest of 2024
247wallst.com22 August 2024 Sentiment: POSITIVE

24/7 Wall St. Insights With a market rotation underway, where should investors seeking opportunities in health care be looking?

Alphatec Holdings, Inc. (ATEC) Q2 2024 Earnings Call Transcript
seekingalpha.com31 July 2024 Sentiment: POSITIVE

Alphatec Holdings, Inc. (NASDAQ:ATEC ) Q2 2024 Results Conference Call July 31, 2024 4:30 PM ET Company Participants Patrick Miles - Chairman and CEO Todd Koning - CFO Conference Call Participants Vik Chopra - Wells Fargo Eric Anderson - TD Cowen Matt Blackman - Stifel Drew Ranieri - Morgan Stanley Aaron Wukmir - Lake Street Capital Markets David Saxon - Needham & Co. Jason Wittes - ROTH Sean Lee - H.C. Wainwright Operator Good afternoon, everyone, and welcome to the webcast of ATEC's Second Quarter Financial Results.

Alphatec's (ATEC) New EOS Insight System to Boost Spine Care
zacks.com25 July 2024 Sentiment: POSITIVE

Alphatec (ATEC) announces the commercial launch of its EOS Insight, an end-to-end spine surgery platform powered by standardized EOSedge scans and artificial intelligence.

Alphatec Holdings, Inc. (ATEC) Q4 2023 Earnings Call Transcript
Seeking Alpha27 February 2024 Sentiment: POSITIVE

Alphatec Holdings, Inc. (ATEC) Q4 2023 Earnings Call Transcript

Alphatec (ATEC) Reports Q4 Loss, Tops Revenue Estimates
Zacks Investment Research27 February 2024 Sentiment: NEGATIVE

Alphatec (ATEC) came out with a quarterly loss of $0.37 per share versus the Zacks Consensus Estimate of a loss of $0.28. This compares to loss of $0.33 per share a year ago.

Alphatec Holdings: Taking Market Share Amid Strong Execution - Buy
Seeking Alpha12 February 2024 Sentiment: POSITIVE

In recent years, Alphatec Holdings has outperformed expectations on a regular basis and successfully taken share in the $8 billion U.S. spinal disorder treatment market. The company is capitalizing on M&A-related disruptions at key competitors, which has created opportunities for Alphatec to grab additional market share. Persistent cash usage has resulted in substantial debt accumulation and material dilution for common shareholders, but the company appears adequately financed to reach cash flow breakeven by 2025.

Alphatec: Still Not Having My Back
Seeking Alpha09 November 2023 Sentiment: NEGATIVE

Alphatec Holdings, Inc.'s focus on growth rather than improving margins raises caution for investors. Despite strong revenue growth, the company continues to experience substantial losses and slow progress on margin improvements. The recent share sales and high debt levels contribute to investor uncertainty about the company's commitment to shareholder value.

Alphatec Holdings, Inc. (ATEC) Q3 2023 Earnings Call Transcript
Seeking Alpha06 November 2023 Sentiment: POSITIVE

Alphatec Holdings, Inc. (NASDAQ:ATEC ) Q3 2023 Earnings Conference Call November 6, 2023 4:30 PM ET Company Participants Pat Miles - Chairman and Chief Executive Officer Todd Koning - Chief Financial Officer Conference Call Participants Brooks O'Neil - Lake Street Capital Markets Matt Blackman - Stifel Matthew O'Brien - Piper Sandler Joshua Jennings - TD Cowen Drew Ranieri - Morgan Stanley Sean Lee - H.C. Wainwright Jason Wittes - ROTH Operator Good afternoon, everyone and welcome to the webcast of ATEC's Third Quarter Financial Results.

Why Alphatec Holdings Stock Plunged Today
The Motley Fool25 October 2023 Sentiment: NEGATIVE

Alphatec just priced an offering of 14.3 million shares at $10.50 per share -- a more than 18% discount from yesterday's close. The offering was filed pursuant to a previously filed shelf registration statement by the company.

What type of business is Alphatec Holdings?

Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders in the United States and internationally. It manufactures and sells implants and instruments through third-party suppliers. The company offers Alpha InformatiX product platform, including EOS imaging system that provides full-body imaging; VEA alignment mobile application, which leverages EOS technology to more quickly quantify alignment parameters on a mobile device; SafeOp Neural InformatiX System that automates electromyographic and somatosensory evoked potential monitoring; and Valence, an intra-operative system that integrates navigation and robotics into spine procedures, as well as Sigma Prone TransPsoas (PTP) Access and PTP Patient Positioning Systems. It also provides split-blade retractors; Sigma-ALIF Access System, a procedure-specific access system; spinal implants and fixation systems comprising NanoTec surface modifications, Calibrate PSX, and Invictus, as well as various standalone implants for height restoration and stabilization. In addition, the company provides biologics comprising 3D ProFuse Osteoconductive Bioscaffold for ease of handling and better endplate-to-endplate contact; AlphaGRAFT Demineralized Bone Matrix (DBM) comprising demineralized human tissues; AlphaGRAFT DBM Fibers comprising demineralized fibers; AlphaGRAFT Cellular Bone Matrix (CBM), a growth factor-enriched cellular bone matrix; AlphaGRAFT CBM that is delivered in granular, fiber, or structural form; BioCORE Moldable Bioactive Graft, a synthetic mineral-collagen composite matrix that can be molded to fit the bone defect; and Amnioshield Amniotic Tissue Barrier, an allograft for spinal surgical barrier applications. The company sells its products through a network of independent sales agents and direct sales representatives. Alphatec Holdings, Inc. was founded in 1990 and is headquartered in Carlsbad, California.

What sector is Alphatec Holdings in?

Alphatec Holdings is in the Healthcare sector

What industry is Alphatec Holdings in?

Alphatec Holdings is in the Medical Devices industry

What country is Alphatec Holdings from?

Alphatec Holdings is headquartered in United States

When did Alphatec Holdings go public?

Alphatec Holdings initial public offering (IPO) was on 12 June 2006

What is Alphatec Holdings website?

https://www.atecspine.com

Is Alphatec Holdings in the S&P 500?

No, Alphatec Holdings is not included in the S&P 500 index

Is Alphatec Holdings in the NASDAQ 100?

No, Alphatec Holdings is not included in the NASDAQ 100 index

Is Alphatec Holdings in the Dow Jones?

No, Alphatec Holdings is not included in the Dow Jones index

When was Alphatec Holdings the previous earnings report?

No data

When does Alphatec Holdings earnings report?

The next expected earnings date for Alphatec Holdings is 27 February 2025